Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells - sprookjes - yvandenbroek - TriplyDB

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

http://www.wikidata.org/entity/Q24563997

about

Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure Role of advanced glycation end products in cellular signaling RAGE-dependent activation of gene expression of superoxide dismutase and vanins by AGE-rich extracts in mice cardiac tissue and murine cardiac fibroblasts.Tunneling-nanotube direction determination in neurons and astrocytes The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function.Huang Gan Formula Eliminates the Oxidative Stress Effects of Advanced Oxidation Protein Products on the Divergent Regulation of the Expression of AGEs Receptors via the JAK2/STAT3 Pathway.Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase.Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling Advanced glycation in health and disease: role of the modern environment.Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1 Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.Regulation of RAGE for attenuating progression of diabetic vascular complications.Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?Biomarkers of aging in Drosophila S100 proteins in cartilage: role in arthritis.Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients.Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice Advanced glycation end product receptor-mediated cellular dysfunction.Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.Uremic Toxicity of Advanced Glycation End Products in CKD.Advanced glycation end products: Key players in skin aging?Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan.Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.AGE restriction in diabetes mellitus: a paradigm shift.Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons The antihypertensive effect of cysteine.Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.Advanced glycation end products (AGE) and diabetes: cause, effect, or both?Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms

P2860

Q21144214-5BAA4F55-5D36-4765-9CB0-FFAAB5331C07 Q27003423-55AD38E1-CC09-4176-B1D8-69A849577FEF Q30318035-C5702C1A-A827-4AC7-A21E-2D445A58C590 Q30532063-655FA7B4-154D-4E92-BF96-88174E8C5E63 Q33278821-0B7F34B0-8C15-4008-934D-EE89BA141A95 Q33561493-B48C2168-9029-47A0-9EE9-05E50F37E18E Q33609776-D3F77CC9-B393-4E2F-A606-03E20EE2030E Q33727690-E3992FE3-5631-439C-B12C-2BCC6F834840 Q33819035-2E42C49F-331A-498B-BBA6-4BECECC62154 Q34409300-BCC8A716-863E-461A-ADB2-F473D748A2FD Q34436007-BEC519D7-40EC-4B4D-97D6-207E41DFB496 Q34557348-541460FC-559D-4C6A-9988-3092C6804A4F Q35025205-673CD7ED-7ED6-49D7-B67C-92C8153D814D Q35060239-C300A7E6-8468-49ED-B6C4-7877AB85CFA5 Q35255473-AA60D57C-C332-45D4-AC5C-27EC21A19F22 Q35494903-7C9561B7-ECB6-4F77-83D4-949120C3A540 Q35578295-1D08DEE1-092C-4EC2-A843-E36713368142 Q35741340-6557DC8F-72C0-4B7C-957E-290474E2E4A8 Q35803078-F403F8D3-3B70-4B64-820D-25270C45FB34 Q35809946-D4B327B5-1F27-4CA0-B4C8-450A852B44EE Q35855642-78A69BE1-D76D-4679-BD72-67DEBC7D7BD1 Q36080001-EC42B9ED-EEC5-4A38-ACCA-3A31C77CC63D Q36081850-E2ADC709-ECA9-4880-AFC1-74542C3433D9 Q36109288-84AE6BBD-B12E-4B3C-BDFE-539DAFA508D0 Q36204007-E5346D7B-FC77-416A-992E-E660F4C1D352 Q36252773-F7284BC9-9C24-44FC-9328-30B11E4FD5CB Q36300685-0D10130E-51EB-4360-BA8A-C92D25029AC7 Q36514906-31961E1D-5898-4799-99B5-0E7F59FC834E Q36643573-6B2D5B77-D318-4563-81AA-648B76F9A6DD Q36778201-9D7B63E3-EE6E-4406-A81C-246445A41022 Q36796216-FC4C450A-A71F-43B5-BCFD-0E94C7CB0457 Q37003623-287DEF6B-5A90-4A4A-9E7F-3C90305C3EF5 Q37214116-0E0F53D8-B2ED-449D-9F88-0481CCD427C4 Q37291570-08B4B55A-518B-4DA9-AB05-9146457BE5A0 Q37362121-6AE3CE94-7E27-45F8-B203-37EE13A6D46B Q37412673-93AF4E5F-E4E3-4AEF-A6F3-DA686655FD34 Q37417494-61DF7F46-F3B7-44EA-A49F-963B4EB42F51 Q37520014-8BC54DD5-6451-49C0-8EDF-03C4BDDE1DF4 Q37626352-5DD8E447-F5A5-4A85-ADBE-968635D862EA Q37636453-04DC3985-BB4F-45F2-8352-55B96F9DF60A

P2860

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

http://www.wikidata.org/entity/Q24563997

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@ast

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@en

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@nl

type

label

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@ast

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@en

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@nl

prefLabel

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@ast

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@en

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@nl

P1433

Q24563997-6A93FA6F-9B08-4358-8C0A-83613DD40F1C

P1476

Q24563997-4DDD8000-7016-4F09-A444-38681D5343E9

P2093

Q24563997-2140A832-4984-45F5-BD77-478A3671818F

Q24563997-9D32BF88-A68B-4D5B-AC07-15553B766C49

Q24563997-A199FBCA-A295-412A-8B69-C2F4E19FE6B2

Q24563997-A1BD2430-D873-45D8-960B-E18369C892F4

Q24563997-ABC5C642-E883-4943-8187-FA9BEABA8690

Q24563997-F19F3E66-651C-4FA6-85FA-C82DEDE1F832

P2860

Q24563997-0C882F3D-DC6A-4F9E-A595-375EBF0AC23B

Q24563997-0FFF4F5A-4922-4F97-8E64-485315EDB9D4

Q24563997-12A85BFD-6FF0-458D-9F1F-C8A694083811

Q24563997-182E50B4-BE1E-4821-8FAF-8DA6778D3FC8

Q24563997-19EFDFCE-72C0-4D71-94A8-3946824D83E3

Q24563997-1BD74844-1E5D-452B-BC9A-323306186CD7

Q24563997-2D064F64-7617-49AE-B839-CFF4765A53D9

Q24563997-30561F99-A452-43F6-987C-092F9E044736

Q24563997-38537CAA-B862-4FFB-8204-770820274012

Q24563997-3ADE68FC-BC40-4056-9887-750E0B451F62

P304

Q24563997-EF66C58E-127E-435C-B9D1-1F4224461CEF

P31

Q24563997-1E54ABEF-D1A0-42F1-8D5A-929973BB1933

P3181

Q24563997-5A429641-DFB1-4848-9CD8-C8B7B84E88EB

P356

Q24563997-00FA82A0-D427-4B7D-AF05-3001E1716F12

P407

Q24563997-89BA39B2-9717-4411-AE06-83FAE6AF2C06

P433

Q24563997-EAC6CF95-938B-446E-87D6-8C8BAE1A2AEB

P478

Q24563997-4A82DF00-FDC5-4405-8E89-FB452385F9AA

P577

Q24563997-51835FED-B0D9-4F1A-9AF6-BE9BFA2ED755

P5875

Q24563997-398E1432-891D-42D0-89B2-18C439014662

P698

Q24563997-3341C8F1-2CE1-4E41-AF26-381CC495C024

P921

Q24563997-6AAAE1C3-3064-4D92-8CD0-8D4734BD0C22

P932

Q24563997-16D57F4C-76BF-4E1F-A216-D0B1D19D90E7

P3181

P356

PNAS.0401588101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Advanced glycation endproduct ...... onse to AGE in mesangial cells

@en

P2093

Changyong Lu

http://www.w3.org/2001/XMLSchema#string

Helen Vlassara

http://www.w3.org/2001/XMLSchema#string

Huixian Liu

http://www.w3.org/2001/XMLSchema#string

John Cijiang He

http://www.w3.org/2001/XMLSchema#string

Li Zhu

http://www.w3.org/2001/XMLSchema#string

Weijing Cai

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

Tobacco smoke is a source of toxic reactive glycation products

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

Oxidants, oxidative stress and the biology of ageing

Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE

Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B

Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.

P304

11767-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4499320

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0401588101

http://www.w3.org/2001/XMLSchema#string

P407

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8420152

http://www.w3.org/2001/XMLSchema#string

P698

15289604

http://www.w3.org/2001/XMLSchema#string

P921

P932

511050

http://www.w3.org/2001/XMLSchema#string